Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae

Status Not yet recruiting

Clinical Trial Summary

The trial attempts to optimize, standardize and simplify the characteristic diagnosis and treatment program of the dominant diseases in our hospital-the sequelae of pelvic inflammatory disease, so as to make it suitable for clinical diagnosis and treatment in primary hospital.

Clinical Trial Description

Sequelae of pelvic inflammatory disease (SPID) is a common cause of chronic pelvic pain, ectopic pregnancy and infertility, which seriously affects the physical and mental health of the patients, quality of life and family happiness. Western medicine for pelvic inflammatory disease sequelae is still lack of effective treatment methods, traditional Chinese medicine treatment of this disease has a unique advantage, with broad prospects for development..Standardized diagnosis and treatment scheme of this project on the one hand, improve and optimize the sequelae of pelvic inflammatory disease, including according to the dialectical treatment of herbal medicine combined with TCM (traditional Chinese medicine enema, external application of Chinese medicine intervention treatment); on the other hand, to observe the clinical curative effect and adverse reaction of traditional Chinese medicine comprehensive treatment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Pelvic Inflammatory Disease

Clinical Trial Details

NCT number	NCT02972151
Study type	Interventional
Source	Shanghai University of Traditional Chinese Medicine
Contact	lianwei xu, Doctor
Phone	64385700-3912
Email	sherryxlw@hotmail.com
Status	Not yet recruiting
Phase	Phase 2
Start date	November 2016
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04723069` - Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases	Phase 2
Recruiting	`NCT03391440` - A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease	Phase 4
Completed	`NCT01671280` - Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)	N/A
Completed	`NCT00115388` - Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease	N/A
Completed	`NCT01236131` - The Role of Novel Organisms in Acute Endometritis	N/A
Completed	`NCT01160640` - The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)	Phase 2
Active, not recruiting	`NCT03994055` - Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer	N/A
Completed	`NCT00871494` - Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan	Phase 3
Completed	`NCT00783419` - Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
Completed	`NCT01799356` - Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials	Phase 4
Recruiting	`NCT05408624` - Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
Completed	`NCT01241110` - To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment	Phase 4
Completed	`NCT00453349` - A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease	Phase 3
Recruiting	`NCT04234945` - Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity	N/A
Recruiting	`NCT06360965` - Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain	N/A
Recruiting	`NCT05648747` - Pelvic Inflammatory Disease in COVID-19 Era
Completed	`NCT01793584` - Surgical Success After Laparoscopic vs Abdominal Hysterectomy	N/A
Completed	`NCT01299259` - Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease	N/A
Completed	`NCT03054402` - First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845	Phase 1
Active, not recruiting	`NCT03828994` - Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II	N/A